TCM treatment for gastro-esophageal reflux disease from 2018 to 2023:an overview of systematic reviews
10.3760/cma.j.cn115398-20240623-00229
- VernacularTitle:2018－2023年中药治疗胃食管反流病系统评价再评价
- Author:
Xueyan JIA
1
;
Jinxiang LIU
;
Huan CHEN
;
Haifeng HE
;
Xiaoquan DU
Author Information
1. 陕西中医药大学附属医院消化二科，咸阳 712000
- Keywords:
Gastroesophageal reflux;
Chinese materia medica;
Overview of systematic reviews
- From:
International Journal of Traditional Chinese Medicine
2025;47(4):541-548
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To overview the systematic reviews/meta-analyses of TCM treatment for gastroesophageal reflux disease (GERD); To provide evidence-based support for clinical decision-making in the treatment of GERD with Chinese materia medica.Methods:Systematic reviews/meta-analyses of RCTs about the treatment of GERD with Chinese materia medica were retrieved from databases of CNKI, Wanfang Data, Chongqing VIP, CBM, EMbase, PubMed and Cochrane Library from January 1, 2018 to December 31, 2023. AMSTAR 2 scale, PRISMA 2020 and GRADE system were used to evaluate the methodological quality, reporting quality and evidence quality of the included studies.Results:A total of 19 systematic reviews/meta-analyses were included. The AMSTAR 2 evaluation showed that 17 of the included studies were rated as low-quality, and 2 were rated as extremely low-quality. The PRISMA 2020 evaluation results showed that the included literature scored 14.5-21 points, with 18 articles having certain reporting defects and 1 article having serious reporting defects. The GRADE evaluation results showed 1 high-quality index, 31 medium-quality indexes, 34 low-quality indexes, and 10 extremely low-quality indexes.Conclusion:TCM has a certain therapeutic effect on GERD, but the overall methodological quality, reporting quality, and evidence quality still need to be further improved.
